BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26053310)

  • 1. Advanced High-Grade Serous Ovarian Cancer: Frequency and Timing of Thoracic Metastases and the Implications for Chest Imaging Follow-up.
    Shinagare AB; O'Neill AC; Cheng S; Somarouthu B; Tirumani SH; Nishino M; Van den Abbeele AD; Ramaiya NH
    Radiology; 2015 Dec; 277(3):733-40. PubMed ID: 26053310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal stromal tumor: optimizing the use of cross-sectional chest imaging during follow-up.
    Shinagare AB; Ip IK; Lacson R; Ramaiya NH; George S; Khorasani R
    Radiology; 2015 Feb; 274(2):395-404. PubMed ID: 25203129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns and Prognostic Importance of Hepatic Involvement in Patients with Serous Ovarian Cancer: A Single-Institution Experience with 244 Patients.
    O'Neill AC; Somarouthu B; Tirumani SH; Braschi-Amirfarzan M; Van den Abbeele AD; Ramaiya NH; Shinagare AB
    Radiology; 2017 Jan; 282(1):160-170. PubMed ID: 27479640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian Cancer: An Evidence-Based, Easy-to-Use Prediction Rule to Optimize the Use of Follow-up Chest CT.
    Shinagare AB; Suh CH; Kim KW; Somarouthu B; Van den Abbeele AD; Ramaiya NH
    J Am Coll Radiol; 2017 Apr; 14(4):499-508. PubMed ID: 27720583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and risk factors of thoracic metastases and optimisation of the use of cross-sectional chest imaging in follow-up patients with cervical cancer.
    Nakao KK; Kido A; Imai T; Abiko K; Fujimoto K; Horie A; Minamiguchi S; Tanaka S; Mandai M; Togashi K
    Clin Radiol; 2019 Apr; 74(4):326.e1-326.e8. PubMed ID: 30771995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic Patterns of Solitary Fibrous Tumors: A Single-Institution Experience.
    O'Neill AC; Tirumani SH; Do WS; Keraliya AR; Hornick JL; Shinagare AB; Ramaiya NH
    AJR Am J Roentgenol; 2017 Jan; 208(1):2-9. PubMed ID: 27762594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of supradiaphragmatic lymph nodes at initial presentation in patients with stage III high-grade serous ovarian cancer.
    McIntosh LJ; O'Neill AC; Bhanusupriya S; Matalon SA; Van den Abbeele AD; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2017 Oct; 42(10):2513-2520. PubMed ID: 28429056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracoscopy for the management of advanced epithelial ovarian cancer--a preliminary report.
    Eisenkop SM
    Gynecol Oncol; 2002 Feb; 84(2):315-20. PubMed ID: 11812093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?
    Perri T; Ben-Baruch G; Kalfon S; Beiner ME; Helpman L; Hogen LB; Shapira-Frommer R; Korach J
    Gynecol Oncol; 2013 Oct; 131(1):27-31. PubMed ID: 23880152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of thoracic recurrence based on pathological features in patients with ovarian epithelial tumors in stage I versus higher stages.
    Matsutani H; Nakai G; Fujiwara S; Takahashi S; Yamamoto K; Ohmichi M; Osuga K
    Jpn J Radiol; 2023 May; 41(5):500-509. PubMed ID: 36575285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of tumour markers in improving the accuracy of conventional chest X-ray and liver echography in the post-operative detection of thoracic and liver metastases from breast cancer.
    Nicolini A; Carpi A; Ferrari P; Anselmi L; Spinelli C; Conte M; Miccoli P
    Br J Cancer; 2000 Dec; 83(11):1412-7. PubMed ID: 11076646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive anterior chest wall metastasis of ovarian cancer and prolonged survival after treatment: a case report.
    Chiu TJ; Chen YJ; Huang CH
    J Reprod Med; 2008 May; 53(5):373-7. PubMed ID: 18567287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of chest CT in the follow-up of ovarian adenocarcinoma.
    Dachman AH; Visweswaran A; Battula R; Jameel S; Waggoner SE
    AJR Am J Roentgenol; 2001 Mar; 176(3):701-5. PubMed ID: 11222208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
    Vargas HA; Huang EP; Lakhman Y; Ippolito JE; Bhosale P; Mellnick V; Shinagare AB; Anello M; Kirby J; Fevrier-Sullivan B; Freymann J; Jaffe CC; Sala E
    Radiology; 2017 Nov; 285(2):482-492. PubMed ID: 28641043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.
    Vargas HA; Miccò M; Hong SI; Goldman DA; Dao F; Weigelt B; Soslow RA; Hricak H; Levine DA; Sala E
    Radiology; 2015 Mar; 274(3):742-51. PubMed ID: 25383459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of chest CT scans in routine ovarian carcinoma follow-up.
    Sella T; Rosenbaum E; Edelmann DZ; Agid R; Bloom AI; Libson E
    AJR Am J Roentgenol; 2001 Oct; 177(4):857-9. PubMed ID: 11566689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?
    Risum S; Høgdall C; Loft A; Berthelsen AK; Høgdall E; Nedergaard L; Lundvall L; Engelholm SA
    Gynecol Oncol; 2010 Mar; 116(3):395-8. PubMed ID: 20042226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.